|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
98.13(B) |
Last
Volume: |
4,069,742 |
Avg
Vol: |
8,519,891 |
52
Week Range: |
$47.94 - $67.82 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
199,132 |
469,488 |
885,133 |
1,877,631 |
Total Sell Value |
$12,080,496 |
$26,266,302 |
$48,317,781 |
$91,052,440 |
Total People Sold |
6 |
7 |
10 |
15 |
Total Sell Transactions |
12 |
19 |
36 |
74 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Brennan Daniel J. |
EVP and CFOOfficer |
|
2014-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
68,487 |
|
- |
|
Mario Ernest |
Director |
|
2013-12-26 |
4 |
AS |
$12.06 |
$120,600 |
D/D |
(10,000) |
384,959 |
|
- |
|
Nicholas Nicholas J Jr |
Director |
|
2013-11-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
15,000 |
22,000 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2013-11-27 |
4 |
S |
$11.70 |
$1,270,583 |
D/D |
(108,595) |
447 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2013-11-26 |
4 |
S |
$11.82 |
$1,005,698 |
D/D |
(85,106) |
109,042 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2013-11-26 |
4 |
OE |
$6.28 |
$296,129 |
D/D |
46,701 |
194,148 |
|
- |
|
Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
|
2013-11-25 |
4 |
S |
$12.05 |
$401,675 |
D/D |
(33,334) |
45,147 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2013-11-25 |
4 |
S |
$12.02 |
$2,915,068 |
D/D |
(242,504) |
147,447 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2013-11-25 |
4 |
OE |
$6.91 |
$1,780,911 |
D/D |
242,504 |
389,951 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2013-11-22 |
4 |
S |
$12.02 |
$1,803,090 |
D/D |
(150,000) |
147,447 |
|
- |
|
Capello Jeffrey D |
EVP & Chief Financial Officer |
|
2013-11-22 |
4 |
OE |
$7.41 |
$1,217,468 |
D/D |
150,000 |
297,447 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2013-11-21 |
4 |
S |
$12.00 |
$1,666,339 |
D/D |
(138,850) |
81,802 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2013-11-21 |
4 |
OE |
$7.16 |
$1,039,152 |
D/D |
138,850 |
220,652 |
|
- |
|
Nicholas Nicholas J Jr |
Director |
|
2013-11-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,000 |
8,000 |
|
- |
|
Nicholas Nicholas J Jr |
Director |
|
2013-11-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,000 |
37,000 |
|
- |
|
Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
|
2013-11-19 |
4 |
S |
$11.94 |
$240,376 |
D/D |
(20,132) |
119,011 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2013-11-11 |
4/A |
S |
$12.02 |
$72,128 |
D/D |
(6,000) |
59,190 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2013-11-11 |
4 |
S |
$12.02 |
$72,128 |
D/D |
(6,000) |
39,190 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2013-11-08 |
4/A |
S |
$11.87 |
$237,402 |
D/D |
(20,000) |
65,190 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2013-11-08 |
4/A |
OE |
$6.31 |
$126,200 |
D/D |
20,000 |
85,190 |
|
- |
|
Mario Ernest |
Director |
|
2013-11-08 |
4 |
S |
$11.73 |
$239,857 |
I/I |
(20,445) |
0 |
|
- |
|
Mario Ernest |
Director |
|
2013-11-08 |
4 |
S |
$11.73 |
$1,351,503 |
D/D |
(115,200) |
394,959 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2013-11-08 |
4 |
S |
$11.87 |
$237,402 |
D/D |
(20,000) |
45,190 |
|
- |
|
Mahoney Michael F |
President & CEO |
|
2013-11-01 |
4 |
D |
$11.75 |
$1,894,899 |
D/D |
(161,268) |
474,430 |
|
- |
|
Mahoney Michael F |
President & CEO |
|
2013-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
341,669 |
635,698 |
|
- |
|
1823 Records found
|
|
Page 8 of 73 |
|
|